Evidence map›Paper›PMID 42350607›Full record

ArticleLeukemia2026

Outcomes of patients with chronic lymphocytic leukemia discontinuing covalent Bruton tyrosine kinase inhibitors due to adverse events.

Anthony G Mansour, Ying Huang, J Phillip Pemberton, Aseel Alsouqi, Adam S Kittai, John C Byrd, Michael R Grever, Cecelia Miller, Gerard Lozanski, Tracy Wiczer and 13 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Anthony G MansourDepartment of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
Ying HuangDivision of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
J Phillip PembertonDepartment of Internal Medicine, Virginia Commonwealth University, Health System, Richmond, VA, USA.
Aseel AlsouqiDivision of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Adam S KittaiIcahn School of Medicine at Mount Sinai, New York, NY, USA.
John C ByrdUPMC Hillman Cancer Center, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-8778-1000
Michael R GreverDivision of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID http://orcid.org/0000-0002-1605-7875
Cecelia MillerDepartment of Pathology, The Ohio State University, Columbus, OH, USA.ORCID http://orcid.org/0000-0001-6110-6069
Gerard LozanskiDepartment of Pathology, The Ohio State University, Columbus, OH, USA.
Tracy WiczerDepartment of Pharmacy, The Ohio State University Arthur G James Cancer Hospital, Columbus, OH, USA.
Jordan LundbergDepartment of Pharmacy, The Ohio State University Arthur G James Cancer Hospital, Columbus, OH, USA.
Lindsay RosenDepartment of Pharmacy, The Ohio State University Arthur G James Cancer Hospital, Columbus, OH, USA.ORCID http://orcid.org/0000-0002-6121-0082
Caitlyn CrawfordDepartment of Pharmacy, The Ohio State University Arthur G James Cancer Hospital, Columbus, OH, USA.
Tyler EverhartDepartment of Pharmacy, The Ohio State University Arthur G James Cancer Hospital, Columbus, OH, USA.ORCID http://orcid.org/0009-0000-6482-842X
Mollie MoranDivision of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Margaret LucasDivision of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Swetha HintonDivision of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Cara GrantierDivision of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Corinne HoffmanDivision of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Mark ReidDivision of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Kerry A RogersDivision of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Seema A BhatDivision of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Jennifer A WoyachDivision of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH, USA. jennifer.woyach@osumc.edu.ORCID http://orcid.org/0000-0002-3403-9144

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42350607

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.